ORGANIC
LETTERS
2012
Vol. 14, No. 12
3024–3027
A New Stereocontrolled Synthetic Route
to (ꢀ)-Echinosporin from D-Glucose via
Padwa Allenylsulfone [3 þ 2]-Anionic
Cycloadditive Elimination
Jakub T. Flasz and Karl J. Hale*
The School of Chemistry and Chemical Engineering, and the CCRCB, Queen’s
University Belfast, Stranmillis Road, Belfast BT9 5AG, Northern Ireland, U.K.
Received April 24, 2012
ABSTRACT
A new formal total synthesis of (ꢀ)-echinosporin has been developed based upon the Padwa [3 þ 2]-cycloadditive elimination reaction of
allenylsulfone 4 with the D-glucose-derived enone 14 which provides cycloadduct 12.
For some time now our group has been interested in the
application of novel, under-exploited cycloaddition reac-
tions in organic synthesis and, in this context, one process
that recently came to our attention is the Padwa, sodium
benzenesulfinate-induced, anionic [3 þ 2]-cycloadditive
elimination reaction of allenylsulfones with R,β-unsatu-
rated carbonyl compounds,1 a process that provides direct
synthetic access to nonsymmetric cyclopentenylsulfones
with complete regiocontrol. Despite the obvious synthetic
advantages that can potentially accrue from use of this
reaction, it has never been deployed successfully in any
complex natural product total synthesis, notwithstanding
the ease with which the resulting cyclopentenylsulfones can
be synthetically manipulated.
Partly out of a desire to apply the Padwa [3 þ 2]-
cycloadditive elimination upon chiral dipolarophile sys-
tems, and partly out of our own natural curiosity to learn
more about the scope and generality of this process, we set
out to examine whether it could be performed stereoselec-
tively on readily available, orthogonally protected
monosaccharide-enones and ene-lactones. If it could, our
aim was to use this chemistry in a new enantioselective
total synthesis of the naturally occurring antitumor agent,
(ꢀ)-echinosporin;2 a challenging, highly strained, acetal-
lactone of shikimate origin2d that has only succumbed to
total synthesis once in Amos B. Smith’s laboratory at Penn.3,4
Our initial efforts toward achieving this goal involved us
investigating the Padwa [3 þ 2]-cycloadditive elimination
of ene-lactone 3 with (phenylsulfonyl)-1,2-propadiene (4)5
to obtain the bicyclic adduct 6, which would then be taken
forward to (ꢀ)-echinosporin by a multistep synthetic
sequence (Scheme 1). However, to our great dismay, the
(2) Isolation: (a) Sato, T.; Kawamoto, I.; Oka, T.; Okachi, R.
J. Antibiot. 1982, 35, 266. (b) Hirayama, N.; Iida, T.; Shirahata, K.;
Ohashi, Y.; Sasada, Y. Bull. Chem. Soc. Jpn. 1983, 56, 287. Bioactivity:
(c) Morimoto, M.; Imai, R. J. Antibiot. 1985, 38, 490. Biosynthetic
studies on (ꢀ)-echinosporin: (d) Dubeler, A.; Krastel, P.; Floss, H. G.;
Zeeck, A. Eur. J. Org. Chem. 2002, 983.
(3) Total synthesis of (ꢀ)-echinosporin: (a) Smith, A. B., III;
Sulikowski, G. A.; Fujimoto, K. J. Am. Chem. Soc. 1989, 111, 8039.
(b) Smith, A. B., III; Sulikowski, G. A.; Sulikowski, M. M.; Fujimoto,
K. J. Am. Chem. Soc. 1992, 114, 2567.
(4) For various other synthetic approaches to echinosporin, see:
(a) Kinsella, M. A.; Kalish, V. J.; Weinreb, S. M. J. Org. Chem. 1990,
55, 105. (b) Forst, J. M. M.S. Thesis, University of Minnesota, 1987.
(c) Wincott, F. E. Ph.D Thesis, Yale University, 1989.
(1) (a) Padwa, A.; Yeske, P. E. J. Am. Chem. Soc. 1988, 110, 1617.
(b) Padwa, A.; Yeske, P. E. J. Org. Chem. 1991, 56, 6386. (c) Padwa, A.;
Watterson, S. H.; Ni, Z. J. Org. Chem. 1994, 59, 3256. (d) Nunez, A., Jr.;
Martin, M. R.; Fraile, A.; Garcia Romano, J. L. Chem.;Eur. J. 2010,
16, 5443.
(5) Stirling, C. J. M. J. Chem. Soc. 1964, 5856.
r
10.1021/ol301090v
Published on Web 05/30/2012
2012 American Chemical Society